Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
CONCLUSION: Re-irradiation with 3D conformal brachytherapy for vaginal recurrence is feasible and safe as long as cumulative dose to surrounding normal organs is limited, and offers a chance to potentially salvage 40% of patients presenting with vaginal recurrence in the setting of prior pelvic radiation.
PMID: 30600093 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Ling DC, Vargo JA, Glaser SM, Kim H, Beriwal S Tags: Gynecol Oncol Source Type: research
More News: Bladder Cancer | Brachytherapy | Cancer | Cancer & Oncology | Colorectal Cancer | Endometrial Cancer | External Beam Therapy | Radiation Therapy | Science | Toxicology